Onderneming IRLAB Therapeutics AB Nasdaq Stockholm
Aandelen
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- SEK | - |
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 61 | 100,0 % | 6 | 100,0 % | -90,71% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
74,3
%
| - | - | 4 | 74,3 % | - |
United Kingdom
25,7
%
| 61 | 100,0 % | 1 | 25,7 % | -97,62% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 01-01-13 |
Chief Executive Officer | 71 | 06-05-17 | |
Nicholas Waters
FOU | Founder | 62 | 01-01-13 |
Director of Finance/CFO | 53 | 01-01-13 | |
Peder Svensson
CTO | Chief Tech/Sci/R&D Officer | 62 | 01-01-16 |
Joakim Tedroff
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-16 |
Susanna Waters
PRN | Corporate Officer/Principal | 58 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 01-01-16 |
Rein Piir
BRD | Director/Board Member | 66 | 01-01-16 |
Chairman | 66 | 01-04-19 | |
Chief Executive Officer | 71 | 06-05-17 | |
Director/Board Member | 62 | 01-01-23 | |
Veronica Wallin
BRD | Director/Board Member | 38 | 01-01-23 |
Daniel Johnsson
BRD | Director/Board Member | 56 | 01-01-23 |
Director/Board Member | 60 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 79 776 | 0 | 0 | 57,48 % |
Aandeel B | 1 | 51 788 630 | 29 815 943 ( 57,57 %) | 0 |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+14,25% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |
- Beurs
- Aandelen
- Koers IRLAB A
- Koers
- Onderneming IRLAB Therapeutics AB